For this purpose, mice models bearing A549/NCI-H292 xenografts expressing a single tumor antigen (e.g. CD19 and HER2) or double antigens (TAAs and PD-L1) were used to evaluate antitumor efficacy of dual-targeted CAR-T cells. This evidence concerns the gene ERBB2 and neoplasm.